Quick Answer
Pediatrix Medical Group, Inc. reported Cash and Equivalents of $375.24 million for fiscal year 2025.
Pediatrix Medical Group, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $375.24M | +63.2% |
| 2024 | $229.94M | +213.9% |
| 2023 | $73.26M | +645.7% |
| 2022 | $9.82M | -97.5% |
| 2021 | $387.39M | -65.5% |
| 2020 | $1.12B | +941.8% |
| 2019 | $107.87M | +164.6% |
| 2018 | $40.77M | +0.8% |
| 2017 | $40.45M | -27.4% |
| 2016 | $55.70M | +8.0% |
| 2015 | $51.57M | +7.6% |
| 2014 | $47.93M | +53.9% |
| 2013 | $31.14M | +46.3% |
| 2012 | $21.28M | +14.4% |
| 2011 | $18.60M | -29.2% |
| 2010 | $26.25M | -1.0% |
| 2009 | $26.50M | +84.7% |
| 2008 | $14.35M | -86.1% |
| 2007 | $102.84M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $340.06M | +227.5% | +51.3% |
| June 30, 2025 | $224.73M | +1058.3% | +127.1% |
| March 31, 2025 | $98.98M | +1137.5% | -57.0% |
| December 31, 2024 | $229.94M | +213.9% | +121.5% |
| September 30, 2024 | $103.83M | +390.3% | +435.2% |
| June 30, 2024 | $19.40M | +231.7% | +142.6% |
| March 31, 2024 | $8.00M | +30.6% | -89.1% |
| December 31, 2023 | $73.26M | +645.7% | +245.9% |
- Pediatrix Medical Group, Inc. showed an increase of +63.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, Pediatrix Medical Group, Inc.’s cash and equivalents has grown by 264.9% (from $102.84 million to $375.24 million).
- The most recent figure is from Pediatrix Medical Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: